|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 4/20/2018 9:58:55 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 1892, Bipartisan Budget Act of 2018, provisions related to Medicare MIPS program, misvalued codes, IPAB repeal, CHIP, Puerto Rico and USVI Medicaid funding, Telehealth, chronic care
H.R. 1625, Consolidated Appropriations Act, 2018, provisions relating to prevention, treatment, and law enforcement to address opioid epidemic; funding for NIH, National Diabetes Prevention Program, community health centers, National Health Service Corps, and Teaching Health Center GME programs; CDC gun violence funding; J-1 Visa,
Funding for Gun Violence Research
Funding for Comprehensive Addiction and Recovery Act (CARA) programs
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Ashley |
McGlone |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 4508, Prompting Real Opportunity, Success, and Prosperity through Education Reform (PROSPER) Act, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 394, Restoring Access to Medication Act of 2017, all provisions
S. 85, Restoring Access to Medication Act of 2017, all provisions
H.R. 1625, Consolidated Appropriations Act, 2018, provisions relating to Fix NICS Act, Dickey Amendment
H.R. 3545, Overdose Prevention and Patient Safety Act, all provisions
H.R. 5009, Jessie's Law, all provisions
H.R. 5311, Comprehensive Addiction and Recovery Act (CARA) 2.0 Act of 2018, all provisions
S. 2456, Comprehensive Addiction and Recovery Act (CARA) 2.0 Act of 2018, all provisions
H.R. 1375, Prescriber Support Act of 2017, all provisions
S. 2135, Fix NICS Act of 2017, all provisions
H.R. 4909, Student, Teachers, and Officers Preventing (STOP) School Violence Act of 2018, all provisions
H.R. 5002, Advancing Cutting-Edge (ACE) Research Act, all provisions
S. 2406, Advancing Cutting-Edge (ACE) Research Act, all provisions
H.R. 878, Right to Try Act of 2017, all provisions
H.R. 2368, Right to Try Act, all provisions
H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, all provisions
S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017, all provisions
H.R. 4191, HHS Cybersecurity Modernization Act, all provisions
H.R. 4163, Cyber Shield Act of 2017, all provisions
S. 2020, Cyber Shield Act of 2017, all provisions
H.R. 4613, Ensuring Patient Access to Healthcare Records Act of 2017
H.R. 2063, Opioid Preventing Abuse through Continuing Education (Opioid PACE) Act of 2017, all provisions
S. 1803, Marijuana Effective Drug Studies Act of 2017, all provisions
H.R. 1318, Preventing Maternal Deaths Act of 2017, all provisions
S. 1112, Maternal Health Accountability Act of 2017, all provisions
H.R. 2851, Stop the Importation and Trafficking of Synthetic Analogues (SITSA) Act of 2017
H.R. 5219, Opioid Prescription Verification Act of 2018, all provisions
42 CFR/Privacy of substance abuse records
Opioid Abuse
Cost-sharing reduction payments and ACA stabilization
Health Savings Accounts - Prescription requirement for over-the-counter medications
Telemedicine
Electronic Health Records (EHR)
Electronic prescribing of controlled substances
Prescription Drug Monitoring Programs (PDMPs)
Interoperability of EHRs and PDMPs
Prior authorization and medically assisted therapy
Continuing Medical Education (CME) requirements for DEA licensure
Gun Violence
Prescription drug pricing/transparency/value/prior authorization burdens
Provider Price Transparency
Continuing Medical Education (CME) and opioid/pain management prescribing
Cybersecurity
Laboratory Developed Tests (LDTs)
Conscience Rights/Delegation of Authority
Title X Funding
Regulatory burdens
FDA oversight of digital health tools/modernization options
In-office Drug Compounding
Virtual Diabetes Prevention Program/Telehealth
Blood pressure device validation/accuracy
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Defense - Dept of (DOD), Drug Enforcement Administration (DEA), Office of Natl Drug Control Policy (NDCP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S. 898, Conrad State 30 and Physician Access Reauthorization Act, all provisions
Competition in healthcare markets
Medical Licensure
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 2059, EHR Regulatory Relief Act, all provisions
H.R. 4580, ACO Improvement Act of 2017, all provisions
H.R. 1892, Bipartisan Budget Act of 2018, provisions relating to Medicare
H.R. 4206, Medicare Care Coordination Improvement Act of 2017, all provisions
S. 2051, Medicare Care Coordination Improvement Act of 2017, all provisions
H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018, all provisions
H.R. 4613, Ensuring Patient Access to Healthcare Records Act of 2017, all provisions
H.R. 3528, Every Prescription Conveyed Securely Act, all provisions
S. 2460, Every Prescription Conveyed Securely Act, all provisions
H.R. 2687, Medicaid Coverage for Addiction Recovery Expansion (Medicaid CARE) Act, all provisions
S. 1169, Medicaid Coverage for Addiction Recovery Expansion (Medicaid CARE) Act, all provisions
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017, all provisions
S. 1016, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2017, provisions relating to telehealth
S. 479, Removing Barriers to Colorectal Cancer Screening Act of 2017, all provisions
H.R. 4097, Medicare Beneficiary Opioid Addiction Treatment Act, all provisions
H.R. 4005, Medicaid Reentry Act, all provisions
H.R. 2938, Road to Recovery Act, all provisions
Medicare program: Medicare Access and CHIP Reauthorization Act (MACRA) implementation
Medicare program: Alternative Payment Models (APMs)
Medicare program: MACRA technical amendments
Medicare program: Independent Payment Advisory Board (IPAB) Repeal
Medicare program: Protecting Access to Medicare Act (PAMA)
Medicare program: Physician office lab testing
Medicare program: Laboratory Developed Tests (LDTs)
Medicare program: Creating Access to Residency Education Act, all provisions
Medicare program: Graduate Medical Education (GME)
Medicare program: Telemedicine
Medicare program: Electronic Health Records (EHR)
Medicare program: EHR Certification
Medicare program: Misvalued Codes
Medicare program: Electronic Prescribing of Controlled Substances
Medicare program: Electronic payments
Medicare program: Provider Price Transparency
Medicare program: Pharmacy Benefit Manager (PBM)
Medicare program: Prescription Drug Price Transparency
Medicare program: Cybersecurity
Medicare program: Health Insurance Portability and Accountability Act (HIPAA)
Medicare program: Program Integrity/enrollment/audit process/prior authorization/clarity of payment policies
Medicare program: eRx and Prior Authorizations
Medicare program: Regulatory Relief
Medicare program: Opioid Use Disorder
Medicare program: Medicare Shared Savings Program (MSSP)/ACOs
Medicare program: Merit-Based Incentive Payment System (MIPS)/scoring formula simplification/episode-based cost measures
Medicare program: MIPS/Medicare physician payments redistribution proposal
Medicare program: MIPS/Advancing Care Information (ACI)/Improvement Activities (IA)
Medicare program: E & M Documentation Guidelines
Medicare program: Quality & patient-generated health data
Medicare program: Quality Information Organizations (QIOs)
Medicare program: Open Payments
Medicare program: Health IT burden
Medicare program: PECOS/Medicare Enrollment/Revocations/Revalidations
Medicare program: Medicare Diabetes Prevention Program
Medicare program: Provider Compliance
Medicare program: Physician Fee Schedule/Zismer Study
Medicare program: Making Accountable Sustainable Oncology Networks (MASON) proposal
Medicare program: CMS Hospital Readmissions Reduction Program/fee-for-service mortality
Medicare program: Fee-for-service payment policies
Medicaid program: Childrens Health Insurance Plan (CHIP) Reauthorization
Medicaid program: Work requirements
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Drug Enforcement Administration (DEA), White House Office, Office of Management & Budget (OMB), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 1876, Good Samaritan Health Professionals Act of 2017, all provisions
S. 781, Good Samaritan Health Professionals Act of 2017, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 2123, Veterans E-Health and Telemedicine Support (VETS) Act of 2017, all provisions
S. 925, Veterans E-Health and Telemedicine Support (VETS) Act of 2017, all provisions
Veterans Choice Program
Telehealth
Scope of Practice
Tricare access
Anywhere to Anywhere Initiative (Telehealth)
Transgender policy
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA), Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
IND |
TAX |
TOB |
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |